Form 4: Rhythm Pharmaceuticals Executive Sells Shares to Cover Tax Obligations

Pamela J. Cramer, Chief Human Resources Officer of Rhythm Pharmaceuticals, sold 15,515 shares of common stock on March 19, 2024, to cover withholding taxes related to vesting restricted stock units.

Summary

• On March 19, 2024, Pamela J. Cramer, the Chief Human Resources Officer of Rhythm Pharmaceuticals, sold 15,515 shares of the company's common stock.
• The sale was executed to cover withholding taxes associated with the vesting of previously reported restricted stock units.
• The shares were sold at a weighted average price of $39.22, with individual transactions ranging from $39.07 to $39.25 per share.
• Following the transaction, Cramer directly owns 30,005 shares of Rhythm Pharmaceuticals.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the transaction is a routine sale to cover tax obligations and doesn't necessarily reflect a change in the executive's confidence in the company.

Industry Context

Executive stock sales are a common occurrence, particularly to cover tax obligations related to equity compensation. The sale itself doesn't necessarily indicate a negative outlook on the company's future, but it's a transaction investors often monitor.

Key Dates